HomeMy Public PortalAbout003-2023 - Approving Updated Zero Tolerance Drug & Alcohol Testing Policy for Roseview BOARD OF PUBLIC WORKS AND SAFETY
RESOLUTION NO. 3-2023
A RESOLUTION APPROVING THE UPDATED SUBSTANCE
ABUSE POLICY FOR THE ROSE VIEW TRANSIT DEPARTMENT
WHEREAS, On November 10, 2010, the City of Richmond, Indiana (City), by and through its Board of
Public Works and Safety (Board), passed the Rose View Transit Substance Abuse Policy for
the Richmond Rose View Transit rural transit system as required by the Federal Transit
Administration (FTA) and the Indiana Department of Transportation (INDOT) and subsequent
updated policies were approved by the Board through prior Resolution No. 7-2016 and prior
Resolution 11-2018; and
WHEREAS. An updated policy titled as the "Drug and Alcohol Testing Policy" (Policy) for the Rose View
Transit System has been provided by INDOT to be approved by all Rural Transportation
Assistance Program (RTAP) clients, effective as of January 1, 2023, which Policy is attached
hereto as Exhibit A, and is incorporated by reference; and
WHEREAS, It is in the best interest of the City of Richmond that the updated Policy be approved by the
Board of Public Works and Safety of the City of Richmond, Indiana for the Rose View Transit
System.
NOW THEREFORE, BE IT RESOLVED by the Board of Public Works and Safety of the City of Richmond,
Indiana, that said Board hereby approves the updated Policy attached as Exhibit A for the Rose View Transit
System, which policy is to be effective as of January 1, 2023
. qAd
Passed and adopted this A-- day of di ) , 2023, by the Board of Public Works and Safety
of the City of Richmond, Indiana.
BOARD OF PUBLIC WORKS AND SAFETY
04,
Vicki Robinson, President
Emi Palm r, Member
Matt Evans, Member
Approved;
M. now, or
DRUG AND ALCOHOL TESTING POLICY
ROSE VIEW TRANSIT
Adopted as of 2023
A. PURPOSE
1) The Rose View Transit provides public transit and paratransit services for
the residents of the City of Richmond. Part of our mission is to ensure that
this service is delivered safely, efficiently, and effectively by establishing a
drug and alcohol-free work environment, and to ensure that the workplace
remains free from the effects of drugs and alcohol in order to promote the
health and safety of employees and the general public. In keeping with
this mission, Rose View Transit declares that the unlawful manufacture,
distribution, dispense, possession, or use of controlled substances or
misuse of alcohol is prohibited for all employees.
2) Additionally, the purpose of this policy is to establish guidelines to
maintain a drug and alcohol-free workplace in compliance with the Drug-
Free Workplace Act of 1988, and the Omnibus Transportation Employee
Testing Act of 1991. This policy is intended to comply with all applicable
Federal regulations governing workplace anti-drug and alcohol programs
in the transit industry. Specifically, the Federal Transit Administration
(FTA) of the U.S. Department of Transportation has published 49 CFR
Part 655, as amended, that mandates urine drug testing and breath
alcohol testing for safety-sensitive positions, and prohibits performance of
safety-sensitive functions when there is a positive test result, or a refusal
to test, The U. S. Department of Transportation (USDOT) has also
published 49 CFR Part 40, as amended, that sets standards for the
collection and testing of urine and breath specimens.
3) Any provisions set forth in this policy that are included under the sole
authority of Rose View Transit and are not provided under the authority of
the above named Federal regulations are underlined. Tests conducted
under the sole authority of Rose View Transit will be performed on non-
USDOT forms and will be separate from USDOT testing in all respects.
B. APPLICABILITY
This Drug and Alcohol Testing Policy applies to all safety-sensitive employees
(full- or part-time) when performing safety sensitive duties. See Attachment A for
a list of employees and the authority under which they are included.
A safety-sensitive function is operation of public transit service including the
operation of a revenue service vehicle (whether or not the vehicle is in revenue
service), maintenance of a revenue service vehicle or equipment used in revenue
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 1
service, security personnel who carry firearms, dispatchers or persons controlling
the movement of revenue service vehicles and any transit employee who
operates a non-revenue service vehicle that requires a Commercial Driver's
License to operate. Maintenance functions include the repair, overhaul, and
rebuild of engines, vehicles and/or equipment used in revenue service. A list of
safety-sensitive positions who perform one or more of the above mentioned
duties is provided in Attachment A. Supervisors are only safety sensitive if they
perform one of the above functions. Volunteers are considered safety sensitive
and subject to testing if they are required to hold a CDL, or receive remuneration
for service in excess of actual expense.
C. DEFINITIONS
Accident: An occurrence associated with the operation of a vehicle even when
not in revenue service, if as a result:
a. An individual dies;
b. An individual suffers a bodily injury and immediately receives
medical treatment away from the scene of the accident; or,
c. One or more vehicles incur disabling damage as the result of the
occurrence and is transported away from the scene by a tow truck
or other vehicle. For purposes of this definition, disabling damage
means damage which precludes departure of any vehicle from the
scene of the occurrence in its usual manner in daylight after simple
repairs. Disabling damage includes damage to vehicles that could
have been operated but would have been further damaged if so
operated, but does not include damage which can be remedied
temporarily at the scene of the occurrence without special tools or
parts, tire disablement without other damage even if no spare tire is
available, or damage to headlights, taillights, turn signals, horn, or
windshield wipers that makes them inoperative.
Adulterated specimen: A specimen that has been altered, as evidence by test
results showing either a substance that is not a normal constituent for that type of
specimen or showing an abnormal concentration of an endogenous substance,
Alcohol: The intoxicating agent in beverage alcohol, ethyl alcohol, or other low
molecular weight alcohols contained in any beverage, mixture, mouthwash,
candy, food, preparation or medication.
Alcohol Concentration: Expressed in terms of grams of alcohol per 210 liters of
breath as indicated by a breath test under 49 CFR Part 40,
Aliquot: A fractional part of a specimen used for testing, It is taken as a sample
representing the whole specimen.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 2
Canceled Test: A drug or alcohol test that has a problem identified that cannot be
or has not been corrected, or which is cancelled. A canceled test is neither
positive nor negative.
Confirmatory Drug Test: A second analytical procedure performed on a different
aliquot of the original specimen to identify and quantify the presence of a specific
drug or metabolite.
Confirmatory Validity Test: A second test performed on a different aliquot of the
original urine specimen to further support a validity test result.
Covered Employee Under FTA Authority: An employee who performs a safety-
sensitive function including an applicant or transferee who is being considered for
hire into a safety-sensitive function (See Attachment A for a fist of covered
employees).
Designated Employer Representative (DER): An employee authorized by the
employer to take immediate action to remove employees from safety-sensitive
duties and to make required decisions in testing. The DER also receives test
results and other communications for the employer, consistent with the
requirements of 49 CFR Parts 40 and 655.
DOT, The Department, DOT Agency: These terms encompass all DOT agencies,
including, but not limited to, the Federal Aviation Administration (FAA), the
Federal Railroad Administration (FRA), the Federal Motor Carrier Safety
Administration (FMCSA), the Federal Transit Administration (FTA), the National
Highway Traffic Safety Administration (NHTSA), the Pipeline and Hazardous
Materials Safety Administration (PHMSA), and the Office of the Secretary (OST).
For purposes of 49 CFR Part 40, the United States Coast Guard (USCG), in the
Department of Homeland Security, is considered to be a DOT agency for drug
testing purposes. These terms include any designee of a DOT agency.
Dilute specimen: A urine specimen with creatinine and specific gravity values that
are lower than expected for human urine.
Disabling damage: Damage which precludes departure of any vehicle from the
scene of the occurrence in its usual manner in daylight after simple repairs.
Disabling damage includes damage to vehicles that could have been operated
but would have been further damaged if so operated, but does not include
damage which can be remedied temporarily at the scene of the occurrence
without special tools or parts, tire disablement without other damage even if no
spare tire is available, or damage to headlights, taillights, turn signals, horn, or
windshield wipers that makes them inoperative.
Drug and Alcohol Testing Policy (Zero Tolerance- v.0421) Page 3
Evidentiary Breath Testing Device (EBT): A device approved by the NHTSA for
the evidential testing of breath at the 0.02 and the 0.04 alcohol concentrations,
and appears on ODAPC's Web page for "Approved Evidential Breath
Measurement Devices" because it conforms with the model specifications
available from NHTSA.
Initial Drug Test: (Screening Drug Test) The test used to differentiate a negative
specimen from one that requires further testing for drugs or drug metabolites.
Initial Specimen Validity Test: The first test used to determine if a urine specimen
is adulterated, diluted, substituted, or invalid
Invalid Result: The result reported by an HHS-certified laboratory in accordance
with the criteria established by the HHS Mandatory Guidelines when a positive,
negative, adulterated, or substituted result cannot be established for a specific
drug or specimen validity test.
Laboratory: Any U.S, laboratory certified by HHS under the National Laboratory
Certification program as meeting standards of Subpart C of the HHS Mandatory
Guidelines for Federal Workplace Drug Testing Programs; or, in the case of
foreign laboratories, a laboratory approved for participation by DOT under this
part.
Limit of Detection (LOD): The lowest concentration at which a measurand can be
identified, but (for quantitative assays) the concentration cannot be accurately
calculated.
Limit of Quantitation: For quantitative assays, the lowest concentration at which
the identity and concentration of the measurand can be accurately established.
Medical Review Officer (MRO): A licensed physician (medical doctor or doctor of
osteopathy) responsible for receiving laboratory results generated by the drug
testing program who has knowledge of substance abuse disorders, and has
appropriate medical training to interpret and evaluate an individual's confirmed
positive test result, together with his/her medical history, and any other relevant
bio-medical information.
Negative Dilute: A drug test result which is negative for the five drug/drug
metabolites but has creatinine and specific gravity values that are lower than
expected for human urine.
Negative result: The result reported by an HHS-certified laboratory to an MRO
when a specimen contains no drug or the concentration of the drug is less than
the cutoff concentration for the drug or drug class and the specimen is a valid
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 4
specimen. An alcohol concentration of less than 0,02 BAC is a negative test
result.
Non-negative test result: A urine specimen that is reported as adulterated,
substituted, invalid, or positive for drug/drug metabolites.
Oxidizing Adulterant: A substance that acts alone or in combination with other
substances to oxidize drugs or drug metabolites to prevent the detection of the
drug or metabolites, or affects the reagents in either the initial or confirmatory
drug test.
Performing (a safety-sensitive function): A covered employee is considered to be
performing a safety-sensitive function and includes any period in which he or she
is actually performing, ready to perform, or immediately available to perform such
functions.
Positive result: The result reported by an HHS- Certified laboratory when a
specimen contains a drug or drug metabolite equal or greater to the cutoff
concentrations.
Prohibited drug: Identified as marijuana, cocaine, opioids, amphetamines, or
phencyclidine as specified in 49 CFR Part 40, as amended.
Reconfirmed: The result reported for a split specimen when the second
laboratory is able to corroborate the original result reported for the primary
specimen.
Rejected for Testing: The result reported by an HHS- Certified laboratory when
no tests are performed for specimen because of a fatal flaw or a correctable flaw
that has not been corrected.
Revenue Service Vehicles: All transit vehicles that are used for passenger
transportation service.
Safety-sensitive functions: Employee duties identified as:
(1) The operation of a transit revenue service vehicle even when the
vehicle is not in revenue service.
(2) The operation of a non-revenue service vehicle by an employee when
the operation of such a vehicle requires the driver to hold a
Commercial Drivers License (CDL).
(3) Maintaining a revenue service vehicle or equipment used in revenue
service.
(4) Controlling the movement of a revenue service vehicle and
(5) Carrying a firearm for security purposes.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 5
Split Specimen Collection: A collection in which the urine collected is divided into
two separate bottles, the primary specimen (Bottle A) and the split specimen
(Bottle B).
Substance Abuse Professional (SAP): A licensed physician (medical doctor or
doctor of osteopathy) or licensed or certified psychologist, social worker,
employee assistance professional, state-licensed or certified marriage and family
therapist, or drug and alcohol counselor (certified by an organization listed at
hftps://www.transportation.goviodapc/sap) with knowledge of and clinical
experience in the diagnosis and treatment of drug and alcohol related disorders.
Substituted specimen: A urine specimen with creatinine and specific gravity
values that are so diminished or so divergent that they are not consistent with
normal human urine.
Test Refusal: The following are considered a refusal to test if the employee:
(1) Fail to appear for any test (except a pre-employment test) within a
reasonable time, as determined by the employer.
(2) Fail to remain at the testing site until the testing process is complete. An
employee who leaves the testing site before the testing process
commences for a pre-employment test has not refused to test.
(3) Fail to attempt to provide a breath or urine specimen. An employee who
does not provide a urine or breath specimen because he or she has left
the testing site before the testing process commenced for a pre-
employment test has not refused to test.
(4) In the case of a directly-observed or monitored urine drug collection, fail to
permit monitoring or observation of your provision of a specimen.
(5) Fail to provide a sufficient quantity of urine or breath without a valid
medical explanation.
(6) Fail or decline to take a second test as directed by the collector or the
employer for drug testing.
(7) Fail to undergo a medical evaluation as required by the MRO or the
employer's Designated Employer Representative (DER).
(8) Fail to cooperate with any part of the testing process.
(9) Fail to follow an observer's instructions to raise and lower clothing and turn
around during a directly-observed test.
(10) Possess or wear a prosthetic or other device used to tamper with the
collection process.
(11) Admit to the adulteration or substitution of a specimen to the collector or
MRO.
(12) Refuse to sign the certification at Step 2 of the Alcohol Testing Form
(ATF).
(13) Fail to remain readily available following an accident.
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 6
(14) As a covered employee, if the MRO reports that you have a verified
adulterated or substituted test result, you have refused to take a drug
test.
Vehicle: A bus, electric bus, van, automobile, rail car, trolley car, trolley bus, or
vessel. A public transit vehicle is a vehicle used for public transportation or for
ancillary services.
Verified negative test: A drug test result reviewed by a medical review officer and
determined to have no evidence of prohibited drug use at or above the minimum
cutoff levels established by the Department of Health and Human Services
(HHS).
Verified positive test: A drug test result reviewed by a medical review officer and
determined to have evidence of prohibited drug use at or above the minimum
cutoff levels specified in 49 CFR Part 40 as revised.
Validity testing: The evaluation of the specimen to determine if it is consistent
with normal human urine. Specimen validity testing will be conducted on all urine
specimens provided for testing under DOT authority. The purpose of validity
testing is to determine whether certain adulterants or foreign substances were
added to the urine, if the urine was diluted, or if the specimen was substituted.
D. EDUCATION AND TRAINING
1) Every covered employee will receive a copy of this policy and will have
ready access to the corresponding federal regulations including 49 CFR
Parts 655 and 40, as amended. In addition, all covered employees will
undergo a minimum of 60 minutes of training on the signs and symptoms
of drug use including the effects and consequences of drug use on
personal health, safety, and the work environment. The training also
includes manifestations and behavioral cues that may indicate prohibited
drug use.
2) All supervisory personnel or company officials who are in a position to
determine employee fitness for duty will receive 60 minutes of reasonable
suspicion training on the physical, behavioral, and performance indicators
of probable drug use and 60 minutes of additional reasonable suspicion
training on the physical, behavioral, speech, and performance indicators of
probable alcohol misuse.
E. PROHIBITED SUBSTANCES
1) Prohibited substances addressed by this policy include the following.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 7
a. Illegally Used Controlled Substance or Drugs Under the Drug-Free
Workplace Act of 1988 any drug or any substance identified in
Schedule I through V of Section 202 of the Controlled Substance Act
(21 U.S.C. 812), and as further defined by 21 CFR 1308.11 through
1308.15 is prohibited at all times in the workplace unless a legal
prescription has been written for the substance. This includes, but is
not limited to: marijuana, amphetamines, opioids, phencyclidine (PCP),
and cocaine, as well as any drug not approved for medical use by the
U.S. Drug Enforcement Administration or the U.S. Food and Drug
Administration. Illegal use includes use of any illegal drug, misuse of
legally prescribed drugs, and use of illegally obtained prescription
drugs. It is important to note that the use of marijuana in any
circumstances remains completely prohibited for any safety-sensitive
employee subject to drug testing under USDOT regulations. The use of
marijuana in any circumstance (including under state recreational
and/or medical marijuana laws) by a safety-sensitive employee is a
violation of this policy and a violation of the USDOT regulation 49 CFR
Part 40, as amended.
Federal Transit Administration drug testing regulations (49 CFR Part
655) require that all employees covered under FTA authority be tested
for marijuana, cocaine, amphetamines, opioids, and phencyclidine as
described in this policy. Illegal use of these five drugs is prohibited at
all times and thus, covered employees may be tested for these drugs
anytime that they are on duty.
b. Legal Drugs: The appropriate use of legally prescribed drugs and non-
prescription medications is not prohibited. However, the use of any
substance which carries a warning label that indicates that mental
functioning, motor skills, or judgment may be adversely affected must
be reported to a Rose View Transit supervisor and the employee is
required to provide a written release from his/her doctor or pharmacist
indicating that the employee can perform his/her safety-sensitive
functions.
c. Alcohol: The use of beverages containing alcohol (including
mouthwash, medication, food, candy) or any other substances
containing alcohol in a manner which violates the conduct listed in this
policy is prohibited.
F. PROHIBITED CONDUCT
1) Illegal use of the drugs listed in this policy and as defined in 49 CFR Part
40, as amended is prohibited at all times. All covered employees are
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 8
prohibited from reporting for duty or remaining on duty if they have used a
prohibited drug as defined in 49 CFR Part 40, as amended.
2) Each covered employee is prohibited from consuming alcohol while
performing safety-sensitive job functions or while on-call to perform safety-
sensitive job functions. If an on-call employee has consumed alcohol,
they must acknowledge the use of alcohol at the time that they are called
to report for duty. The covered employee will subsequently be relieved of
his/her on-call responsibilities and subject to discipline for not fulfilling
his/her on-call responsibilities.
3) The Transit Department shall not permit any covered employee to perform
or continue to perform safety-sensitive functions if it has actual knowledge
that the employee is using alcohol
4) Each covered employee is prohibited from reporting to work or remaining
on duty requiring the performance of safety-sensitive functions while
having an alcohol concentration of 0.04 or greater regardless of when the
alcohol was consumed.
a. An employee with a breath alcohol concentration which measures
0.02-0.039 is not considered to have violated the USDOT-FTA drug
and alcohol regulations, provided the employee hasn't consumed
the alcohol within four (4) hours of performing a safety-sensitive
duty. However, if a safety-sensitive employee has a breath alcohol
concentration of 0.02-0.039, USDOT-FTA regulations require the
employee to be removed from the performance of safety-sensitive
duties until:
i. The employee's alcohol concentration measures less than
0.02; or
ii. The start of the employee's next regularly scheduled duty
period, but not less than eight hours following administration
of the test.
5) No covered employee shall consume alcohol for eight (8) hours following
involvement in an accident or until he/she submits to the post-accident
drug/alcohol test, whichever occurs first.
6) No covered employee shall consume alcohol within four (4) hours prior to
the performance of safety-sensitive job functions.
7) Rose View Transit, under its own authority, also prohibits the consumption
of alcohol at all times the employee is on duty, or anytime the employee is
in uniform.
_
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 9
8) Consistent with the Drug-free Workplace Act of 1988, all Rose View
Transit employees are prohibited from engaging in the unlawful
manufacture, distribution, dispensing, possession, or use of prohibited
substances in the work place including transit system premises and transit
vehicles.
G. DRUG STATUTE CONVICTION
Consistent with the Drug Free Workplace Act of 1998, all employees are required
to notify the Rose View Transit management of any criminal drug statute
conviction for a violation occurring in the workplace within five days after such
conviction. Failure to comply with this provision shall result in disciplinary action
as defined in Section Q of this policy.
H. TESTING REQUIREMENTS
1) Analytical urine drug testing and breath testing for alcohol will be
conducted as required by 49 CFR Part 40 as amended. All employees
covered under FTA authority shall be subject to testing prior to performing
safety-sensitive duty, for reasonable suspicion, following an accident, and
random as defined in Section K, L, M, and N of this policy, and return to
duty/follow-up.
2) A drug test can be performed any time a covered employee is on duty. A
reasonable suspicion, random, or follow-up alcohol test can only be
performed just before, during, or after the performance of a safety-
sensitive job function. Under Rose View Transit authority, a non-DOT
alcohol test can be performed any time a covered employee is on duty.
3) All covered employees will be subject to urine drug testing and breath
alcohol testing as a condition of ongoing employment with Rose View
Transit. Any safety-sensitive employee who refuses to comply with a
request for testing shall be removed from duty and subject to discipline as
defined in Section Q of this policy.
I. DRUG TESTING PROCEDURES
1) Testing shall be conducted in a manner to assure a high degree of
accuracy and reliability and using techniques, equipment, and laboratory
facilities which have been approved by the U.S. Department of Health and
Human Service (NHS). All testing will be conducted consistent with the
Drug Will Alcohol Testing Policy(Zero Tolerance - v.0421) Page 10
procedures set forth in 49 CFR Part 40, as amended. The procedures will
be performed in a private, confidential manner and every effort will be
made to protect the employee, the integrity of the drug testing procedure,
and the validity of the test result.
2) The drugs that will be tested for include marijuana, cocaine, opioids,
amphetamines, and phencyclidine. After the identity of the donor is
checked using picture identification, a urine specimen will be collected
using the split specimen collection method described in 49 CFR Part 40,
as amended. Each specimen will be accompanied by a DOT Custody and
Control Form and identified using a unique identification number that
attributes the specimen to the correct individual. The specimen analysis
will be conducted at a HHS certified laboratory. An initial drug screen and
validity test will be conducted on the primary urine specimen. For those
specimens that are not negative, a confirmatory Gas
Chromatography/Mass Spectrometry (GC/MS) or Liquid
Chromatography/Mass Spectrometry (LC/MS) test will be performed. The
test will be considered positive if the amounts of the drug(s) and/or its
metabolites identified by the GC/MS or LC/MS test are above the
minimum thresholds established in 49 CFR Part 40, as amended.
3) The test results from the HHS certified laboratory will be reported to a
Medical Review Officer, A Medical Review Officer (MRO) is a licensed
physician with detailed knowledge of substance abuse disorders and drug
testing. The MRO will review the test results to ensure the scientific
validity of the test and to determine whether there is a legitimate medical
explanation for a confirmed positive, substitute, or adulterated test result.
The MRO will attempt to contact the employee to notify the employee of
the non-negative laboratory result, and provide the employee with an
opportunity to explain the confirmed laboratory test result. The MRO will
subsequently review the employee's medical history/medical records as
appropriate to determine whether there is a legitimate medical explanation
for a non-negative laboratory result. If no legitimate medical explanation is
found, the test will be verified positive or refusal to test and reported to
Rose View Transit. If a legitimate explanation is found, the MRO will
report the test result as negative.
4) If the test is invalid without a medical explanation, a retest will be
conducted under direct observation. Employees do not have access to a
test of their split specimen following an invalid result,
5) Any covered employee who questions the results of a required drug test
may request that the split sample be tested. The split sample test must be
conducted at a second HHS-certified laboratory. The test must be
conducted on the split sample that was provided by the employee at the
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 11
same time as the primary sample. The method of collecting, storing, and
testing the split sample will be consistent with the procedures set forth in
49 CFR Part 40, as amended. The employee's request for a split sample
test must be made to the Medical Review Officer within 72 hours of notice
of the original sample verified test result. Requests after 72 hours will only
be accepted at the discretion of the MRO if the delay was due to
documentable facts that were beyond the control of the employee. Rose
View Transit will ensure that the cost for the split specimen analysis is
covered in order for a timely analysis of the sample, however Rose View
Transit will seek reimbursement for the split sample test from the
employee.
6) If the analysis of the split specimen fails to confirm the presence of the
drug(s) detected in the primary specimen, if the split specimen is not able
to be analyzed, or if the results of the split specimen are not scientifically
adequate, the MRO will declare the original test to be canceled.
7) The split specimen will be stored at the initial laboratory until the analysis
of the primary specimen is completed. If the primary specimen is
negative, the split will be discarded. If the primary specimen is positive, it
will be retained in frozen storage for one year and the split specimen will
also be retained for one year. If the primary is positive, the primary and the
split will be retained for longer than one year for testing if so requested by
the employee through the Medical Review Officer, or by the employer, by
the MRO, or by the relevant DOT agency.
8) Observed collections
a. Consistent with 49 CFR Part 40, as amended, collection under
direct observation (by a person of the same gender) with no
advance notice will occur if:
i. The laboratory reports to the MRO that a specimen is invalid,
and the MRO reports to Rose View Transit that there was
not an adequate medical explanation for the result;
ii. The MRO reports to Rose View Transit that the original
positive, adulterated, or substituted test result had to be
cancelled because the test of the split specimen could not be
performed;
iii. The laboratory reported to the MRO that the specimen was
negative-dilute with a creatinine concentration greater than
or equal to 2 mg/dL but less than or equal to 5 mg/dL, and
the MRO reported the specimen as negative-dilute and that
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 12
a second collection must take place under direct observation
(see §40.197(b)(1)).
iv, The collector observes materials brought to the collection
site or the employee's conduct clearly indicates an attempt to
tamper with a specimen;
v. The temperature on the original specimen was out of range;
vi. Anytime the employee is directed to provide another
specimen because the original specimen appeared to have
been tampered with.
vii, All follow-up-tests; or
viii. All return-to-duty tests
J. ALCOHOL TESTING PROCEDURES
1) Tests for breath alcohol concentration will be conducted utilizing a
National Highway Traffic Safety Administration (NHTSA)-approved
Evidential Breath Testing device (EBT) operated by a trained Breath
Alcohol Technician (BAT), A list of approved EBTs can be found on
ODAPC's Web page for "Approved Evidential Breath Measurement
Devices". Alcohol screening tests may be performed using a non-
evidential testing device (alcohol screening device (ASD)) which is also
approved by NHTSA. A list of approved ASDs can be found on ODAPC's
Web page for "Approved Screening Devices to Measure Alcohol in Bodily
Fluids". If the initial test indicates an alcohol concentration of 0.02 or
greater, a second test will be performed to confirm the results of the initial
test. The confirmatory test must occur on an EBT. The confirmatory test
will be conducted no sooner than fifteen minutes after the completion of
the initial test. The confirmatory test will be performed using a NHTSA-
approved EBT operated by a trained BAT. The EBT will identify each test
by a unique sequential identification number. This number, time, and unit
identifier will be provided on each EBT printout. The EBT printout, along
with an approved alcohol testing form, will be used to document the test,
the subsequent results, and to attribute the test to the correct employee.
The test will be performed in a private, confidential manner as required by
49 CFR Part 40, as amended. The procedure will be followed as
prescribed to protect the employee and to maintain the integrity of the
alcohol testing procedures and validity of the test result.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 13
2) A confirmed alcohol concentration of 0.04 or greater will be considered a
positive alcohol test and in violation of this policy. The consequences of a
positive alcohol test are described in Section Q. of this policy. Even
though an employee who has a confirmed alcohol concentration of 0.02 to
0.039 is not considered positive, the employee shall still be removed from
duty for at least eight hours or for the duration of the work day whichever
is longer and will be subject to the consequences described in Section Q
of this policy. An alcohol concentration of less than 0.02 will be
considered a negative test.
3) Rose View Transit affirms the need to protect individual dignity, privacy,
and confidentiality throughout the testing process. If at any time the
integrity of the testing procedures or the validity of the test results is
compromised, the test will be canceled. Minor inconsistencies or
procedural flaws that do not impact the test result will not result in a
cancelled test,
4) The alcohol testing form (ATF) required by 49 CFR Part 40 as amended,
shall be used for all FTA required testing. Failure of an employee to sign
step 2 of the ATF will be considered a refusal to submit to testing.
K. PRE-EMPLOYMENT TESTING
1) All applicants for covered transit positions shall undergo urine drug testing
prior to performance of a safety-sensitive function.
a. All offers of employment for covered positions shall be extended
conditional upon the applicant passing a drug test. An applicant will
not be allowed to perform safety-sensitive functions unless the
applicant takes a drug test with verified negative results.
b. An employee shall not be placed, transferred or promoted into a
position covered under FTA authority or company authority until the
employee takes a drug test with verified negative results.
c. If an applicant fails a pre-employment drug test, the conditional
offer of employment shall be rescinded and the applicant will be
provided with a list of at least two (2) USDOT qualified Substance
Abuse Professionals. Failure of a pre-employment drug test will
disqualify an applicant for employment for a period of at least one
year. Before being considered for future employment the applicant
must provide the employer proof of having successfully completed
a referral, evaluation and treatment plan as described in section
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 14
655.62 of subpart G. The cost for the assessment and any
subsequent treatment will be the sole responsibility of the applicant.
d. When an employee being placed, transferred, or promoted from a
non-covered position to a position covered under FTA authority or
company authority submits a drug test with a verified positive result,
the employee shall be subject to disciplinary action in accordance
with Section Q herein.
e. If a pre-employment test is canceled, Rose View Transit will require
the applicant to take and pass another pre-employment drug test.
f. In instances where a FTA covered employee does not perform a
safety-sensitive function for a period of 90 consecutive days or
more regardless of reason, and during that period is not in the
random testing pool the employee will be required to take a pre-
employment drug test under 49 CFR Part 655 and have negative
test results prior to the conduct of safety-sensitive job functions.
g. Following a negative dilute the employee will be required to
undergo another test. Should this second test result in a negative
dilute result, the test will be considered a negative and no additional
testing will be required unless directed to do so by the MRO.
h. Applicants are required (even if ultimately not hired) to provide
Rose View Transit with signed written releases requesting USDOT
drug and alcohol records from all previous, USDOT-covered,
employers that the applicant has worked for within the last two
years. Failure to do so will result in the employment offer being
rescinded, Rose View Transit is required to ask all applicants (even
if ultimately not hired) if they have tested positive or refused to test
on a pre-employment test for a USDOT covered employer within
the last two years. If the applicant has tested positive or refused to
test on a pre-employment test for a USDOT covered employer, the
applicant must provide Rose View Transit proof of having
successfully completed a referral, evaluation and treatment plan as
described in section 655.62 of subpart G.
L. REASONABLE SUSPICION TESTING
1) All Rose View Transit FTA covered employees will be subject to a
reasonable suspicion drug and/or alcohol test when the employer has
reasonable suspicion to believe that the covered employee has used a
prohibited drug and/or engaged in alcohol misuse. Reasonable suspicion
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 15
shall mean that there is objective evidence, based upon specific,
contemporaneous, articulable observations of the employee's appearance,
behavior, speech or body odor that are consistent with possible drug use
and/or alcohol misuse. Reasonable suspicion referrals must be made by
one or more supervisors who are trained to detect the signs and
symptoms of drug and alcohol use, and who reasonably concludes that an
employee may be adversely affected or impaired in his/her work
performance due to possible prohibited substance abuse or alcohol
misuse. A reasonable suspicion alcohol test can only be conducted just
before, during, or just after the performance of a safety-sensitive job
function. However, under Rose View Transit's authority, a non-DOT
reasonable suspicion alcohol test may be performed any time the covered
employee is on duty. A reasonable suspicion drug test can be performed
any time the covered employee is on duty.
2) Rose View Transit shall be responsible for transporting the employee to
the testing site. Supervisors should avoid placing themselves and/or
others into a situation which might endanger the physical safety of those
present. The employee shall be placed on administrative leave pending
disciplinary action described in Section Q of this policy. An employee who
refuses an instruction to submit to a drug/alcohol test shall not be
permitted to finish his or her shift and shall immediately be placed on
administrative leave pending disciplinary action as specified in Section Q
of this policy.
3) A written record of the observations which led to a drug/alcohol test based
on reasonable suspicion shall be prepared and signed by the supervisor
making the observation. This written record shall be submitted to the
Rose View Transit system.
4) When there are no specific, contemporaneous, articulable objective facts
that indicate current drug or alcohol use, but the employee (who is not
already a participant in a treatment program) admits the abuse of alcohol
or other substances to a supervisor in his/her chain of command, the
employee shall be referred for assessment and treatment consistent with
Section Q of this policy. Rose View Transit shall place the employee on
administrative leave in accordance with the provisions set forth under
Section Q of this policy. Testing in this circumstance would be performed
under the direct authority of the Rose View Transit system. Since the
employee self-referred to management, testing under this
circumstance would not be considered a violation of this policy or a
positive test result under Federal authority. However, self-referral
does not exempt, the covered employee from testing under Federal
authority as specified in Sections L through N of this policy or the
associated consequences as specified in Section Q.
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 16
M. POST-ACCIDENT TESTING
1) FATAL ACCIDENTS — A covered employee will be required to undergo
urine and breath testing if they are involved in an accident with a transit
vehicle, whether or not the vehicle is in revenue service at the time of the
accident, that results in a fatality. This includes all surviving covered
employees that are operating the vehicle at the time of the accident and
any other whose performance could have contributed to the accident, as
determined by the employer using the best information available at the
time of the decision.
2) NON-FATAL ACCIDENTS — A post-accident test of the employee
operating the public transportation vehicle will be conducted if an accident
occurs and at least one of the following conditions is met:
a. The accident results in injuries requiring immediate medical
treatment away from the scene, unless the covered employee can
be completely discounted as a contributing factor to the accident.
b. One or more vehicles incurs disabling damage as a result of the
occurrence and must be transported away from the scene, unless
the covered employee can be completely discounted as a
contributing factor to the accident
In addition, any other covered employee whose performance could have
contributed to the accident, as determined by the employer using the best
information available at the time of the decision, will be tested.
As soon as practicable following an accident, as defined in this policy, the
transit supervisor investigating the accident will notify the transit employee
operating the transit vehicle and all other covered employees whose
performance could have contributed to the accident of the need for the test.
The supervisor will make the determination using the best information available
at the time of the decision.
The appropriate transit supervisor shall ensure that an employee, required to
be tested under this section, is tested as soon as practicable, but no longer
than eight (8) hours of the accident for alcohol, and no longer than 32 hours for
drugs. If an alcohol test is not performed within two hours of the accident, the
Supervisor will document the reason(s) for the delay. If the alcohol test is not
conducted within (8) eight hours, or the drug test within 32 hours, attempts to
conduct the test must cease and the reasons for the failure to test documented.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 17
Any covered employee involved in an accident must refrain from alcohol use for
eight (8) hours following the accident, or until he/she undergoes a post-accident
alcohol test.
An employee who is subject to post-accident testing who fails to remain readily
available for such testing, including notifying a supervisor of his or her location
if he or she leaves the scene of the accident prior to submission to such test,
may be deemed to have refused to submit to testing.
Nothing in this section shall be construed to require the delay of necessary
medical attention for the injured following an accident, or to prohibit an
employee from leaving the scene of an accident for the period necessary to
obtain assistance in responding to the accident, or to obtain necessary
emergency medical care.
In the rare event that Rose View Transit is unable to perform an FTA drug and
alcohol test (i.e., employee is unconscious, employee is detained by law
enforcement agency), Rose View Transit may use drug and alcohol post-
accident test results administered by local law enforcement officials in lieu of
the FTA test. The local law enforcement officials must have independent
authority for the test and the employer must obtain the results in conformance
with local law.
N. RANDOM TESTING
1) All covered employees will be subjected to random, unannounced testing.
The selection of employees shall be made by a scientifically valid method
of randomly generating an employee identifier from the appropriate pool of
safety-sensitive employees. Employees who may be covered under
company authority will be selected from a pool of non-DOT-covered
employees.
2) The dates for administering unannounced testing of randomly selected
employees shall be spread reasonably throughout the calendar year, day
of the week and hours of the day.
3) The number of employees randomly selected for drug/alcohol testing
during the calendar year shall be not less than the percentage rates set
each year by the FTA administrator. The current year testing rates can be
viewed online at https://www.transportation.gov/odapc/random-testing-
rates.
4) Each covered employee shall be in a pool from which the random
selection is made. Each covered employee in the pool shall have an
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 18
equal chance of selection each time the selections are made. Employees
will remain in the pool and subject to selection, whether or not the
employee has been previously tested. There is no discretion on the part
of management in the selection.
5) Covered transit employees that fall under the Federal Transit
Administration regulations will be included in one random pool maintained
separately from the testing pool of non-safety-sensitive employees that
are included solely under Rose View Transit authority.
6) Random tests can be conducted at any time during an employee's shift for
drug testing. Alcohol random tests can only be performed just before,
during, or just after the performance of a safety sensitive duty. However,
under Rose View Transit's authority, a non-DOT random alcohol test may
be performed any time the covered employee is on duty. Testing can
occur during the beginning, middle, or end of an employee's shift.
7) Employees are required to proceed immediately to the collection site upon
notification of their random selection.
O. RETURN-TO-DUTY TESTING
Rose View Transit will terminate the employment of any employee that tests
positive or refuses a test as specified in section Q of this policy. However, in the
rare event an employee is reinstated with court order or other action beyond the
control of the transit system, the employee must complete the return-to-duty
process prior to the performance of safety-sensitive functions. All covered
employees who previously tested positive on a drug or alcohol test or refused a
test, must test negative for drugs, alcohol (below 0.02 for alcohol), or both and be
evaluated and released by the Substance Abuse Professional before returning to
work. Following the initial assessment, the SAP will recommend a course of
rehabilitation unique to the individual. The SAP will recommend the return-to-
duty test only when the employee has successfully completed the treatment
requirement and is known to be drug and alcohol-free and there are no undue
concerns for public safety. The SAP will determine whether the employee
returning to duty will require a return-to-duty drug test, alcohol test, or both.
P. FOLLOW-UP TESTING
Covered employees that have returned to duty following a positive or refused test
will be required to undergo frequent, unannounced drug and/or alcohol testing
following their return-to-duty test. The follow-up testing will be performed for a
period of one to five years with a minimum of six tests to be performed the first
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 19
year. The frequency and duration of the follow-up tests (beyond the minimums)
will be determined by the SAP reflecting the SAP's assessment of the
employee's unique situation and recovery progress. Follow-up testing should be
frequent enough to deter and/or detect a relapse. Follow-up testing is separate
and in addition to the random, post-accident, reasonable suspicion and return-to-
duty testing.
In the instance of a self-referral or a management referral, the employee will be
subject to non-USDOT follow-up tests and follow-up testing plans modeled using
the process described in 49 CFR Part 40, However, all non-USDOT follow-up
tests and all paperwork associated with an employee's return-to-work agreement
that was not precipitated by a positive test result (or refusal to test) does not
constitute a violation of the Federal regulations will be conducted under company
authority and will be performed using non-DOT testing forms.
Q. RESULT OF DRUG/ALCOHOL TEST
1) Any covered employee that has a verified positive drug or alcohol test, or
test refusal, will be removed from his/her safety-sensitive position,
informed of educational and rehabilitation programs available, and will be
provided with a list of at least two (2) USDOT qualified Substance Abuse
Professionals (SAP) for assessment, and will be terminated.
2) Following a negative dilute the employee will be required to undergo
another test. Should this second test result in a negative dilute result, the
test will be considered a negative and no additional testing will be required
unless directed to do so by the MRO.
3) Refusal to submit to a drug/alcohol test shall be considered equivalent to a
positive test result and a direct act of insubordination and shall result in
termination and referral to a list of USDOT qualified SAPs. A test refusal
is defined as any of the following circumstances:
a. Fail to appear for any test (except a pre-employment test) within a
reasonable time, as determined by the employer.
b. Fail to remain at the testing site until the testing process is
complete. An employee who leaves the testing site before the
testing process commences for a pre-employment test has not
refused to test.
c. Fail to attempt to provide a breath or urine specimen. An employee
who does not provide a urine or breath specimen because he or
she has left the testing site before the testing process commenced
for a pre-employment test has not refused to test.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 20
d. In the case of a directly-observed or monitored urine drug
collection, fail to permit monitoring or observation of your provision
of a specimen.
e. Fail to provide a sufficient quantity of urine or breath without a valid
medical explanation.
f. Fail or decline to take a second test as directed by the collector or
the employer for drug testing.
g. Fail to undergo a medical evaluation as required by the MRO or the
employer's Designated Employer Representative (DER).
h. Fail to cooperate with any part of the testing process.
i. Fail to follow an observer's instructions to raise and lower clothing
and turn around during a directly-observed test.
j. Possess or wear a prosthetic or other device used to tamper with
the collection process.
k. Admit to the adulteration or substitution of a specimen to the
collector or MRO.
I. Refuse to sign the certification at Step 2 of the Alcohol Testing
Form (ATF).
m. Fail to remain readily available following an accident,
n. As a covered employee, if the MRO reports that you have a verified
adulterated or substituted test result, you have refused to take a
drug test.
4) An alcohol test result of ._0.02 to 5 0.039 BAC shall result in the removal of
the employee from duty for eight hours or the remainder or the work day
whichever is longer. The employee will not be allowed to return to safety-
sensitive duty for his/her next shift until he/she submits to a NONDOT
alcohol test with a result of less than 0.02 BAC.
5) In the instance of a self-referral or a management referral, disciplinary
action against the employee shall include:
a. Mandatory referral for an assessment by an employer approved
counseling professional for assessment, formulation of a treatment
plan, and execution of a return-to-work agreement',
b. Failure to execute, or remain compliant with the return-to-work
agreement shall result in termination from Rose View Transit
employment.
i. Compliance with the return-to-work agreement means that
the employee has submitted to a drug/alcohol test
immediately prior to returning to work; the result of that test
is negative; the employee is cooperating with his/her
recommended treatment program; and, the employee has
agreed to periodic unannounced follow-up testing as
described in Section P of this policy; however, all follow-up
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 21
testing performed as part of a return-to-work agreement
required under section Q of this policy is under the sole
authority of Rose View Transit and will be performed using
non-DOT testing forms.
c. Refusal to submit to a periodic unannounced follow-up drug/alcohol
test shall be considered a direct act of insubordination and shall
result in termination. All tests conducted as part of the return-
to-work agreement will be conducted under company authority
and will be performed using non-DOT testing forms.
d. A self-referral or management referral to the employer's
counseling professional that was not precipitated by a positive
test result does not constitute a violation of the Federal
regulations and will not be considered as a positive test result
in relation to the progressive discipline defined in Section Q of
this policy.
e. Periodic unannounced follow-up drug/alcohol testing conducted as
a result of a self-referral or management referral which results in a
verified positive shall be considered a positive test result in relation
to the progressive discipline defined in Section Q of this policy.
f. A Voluntary Referral does not shield an employee from disciplinary
action or guarantee employment with Rose View Transit.
g. A Voluntary Referral does not shield an employee from the
requirement to comply with drug and alcohol testing.
6) Failure of an employee to report within five days a criminal drug statute
conviction for a violation occurring in the workplace shall result in
termination.
R. GRIEVANCE AND APPEAL
The consequences specified by 49 CFR Part 40.149 (c) for a positive test or test
refusal is not subject to arbitration.
S. PROPER APPLICATION OF THE POLICY
Rose View Transit is dedicated to assuring fair and equitable application of this
substance abuse policy. Therefore, supervisors/managers are required to use
and apply all aspects of this policy in an unbiased and impartial manner. Any
supervisor/manager who knowingly disregards the requirements of this policy, or
who is found to deliberately misuse the policy in regard to subordinates, shall be
subject to disciplinary action, up to and including termination,
T. INFORMATION DISCLOSURE
Drug and Alcohol Testing Policy(Zero Tolerance- v.0421) Page 22
1) Drug/alcohol testing records shall be maintained by the Rose View Transit
Drug and Alcohol Program Manager and, except as provided below or by
law, the results of any drug/alcohol test shall not be disclosed without
express written consent of the tested employee,
2) The employee, upon written request, is entitled to obtain copies of any
records pertaining to their use of prohibited drugs or misuse of alcohol
including any drug or alcohol testing records. Covered employees have
the right to gain access to any pertinent records such as equipment
calibration records, and records of laboratory certifications. Employees
may not have access to SAP follow-up testing plans.
3) Records of a verified positive drug/alcohol test result shall be released to
the Drug and Alcohol Program Manager, and other transit system
management personnel on a need-to-know basis,
4) Records will be released to a subsequent employer only upon receipt of a
written request from the employee.
5) Records of an employee's drug/alcohol tests shall be released to the
adjudicator in a grievance, lawsuit, or other proceeding initiated by or on
behalf of the tested individual arising from the results of the drug/alcohol
test. The records will be released to the decision maker in the proceeding.
6) Records will be released to the National Transportation Safety Board
during an accident investigation.
7) Information will be released in a criminal or civil action resulting from an
employee's performance of safety-sensitive duties, in which a court of
competent jurisdiction determines that the drug or alcohol test information
is relevant to the case and issues an order to the employer to release the
information. The employer will release the information to the decision
maker in the proceeding with a binding stipulation that it will only be
released to parties of the proceeding.
8) Records will be released to the DOT or any DOT agency with regulatory
authority over the employer or any of its employees.
9) Records will be released if requested by a Federal, state or local safety
agency with regulatory authority over Rose View Transit or the employee.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 23
10)1f a party seeks a court order to release a specimen or part of a specimen
contrary to any provision of Part 40 as amended, necessary legal steps to
contest the issuance of the order will be taken
11)In cases of a contractor or sub-recipient of a state department of
transportation, records will be released when requested by such agencies
that must certify compliance with the regulation to the FTA.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 24
This Policy was adopted by the Board of Public Works & Safety on 2023.
Drug and Alcohol Testing Policy(Zero Tolerance - v.0421) Page 25
Attachment A
Job Title Job Duties Testing Authority
Fixed Route Bus Driver Drives on a time-schedule FTA
Paratransit Driver Drives Demand-Response Safety Sensitive
Dispatcher Dispatches Demand Response Safety Sensitive
Fleet Maintenance Fuels/Details Fleet Safety Sensitive
Drug and Alcohol Testing Policy(Zero Tolerance—v.0421) Page 26
Attachment B Contacts
Any questions regarding this policy or any other aspect of the substance abuse
policy should be directed to the following individual(s).
Drug and Alcohol Program Manager
Name:Terri Quinter
Title: Manager
Address: 401 South "Q" St. Richmond, IN 47374
Telephone Number: 765-983-7227
Medical Review Officer
Name:Richard Weinstein
Title: Medical Review Officer
Address 2800 Black LK PI Ste A Philadelphia, PA 19154
Telephone Number: 800-624-3784
Substance Abuse Professional #1
Name:Mary Brown
Title: Substance Abuse Professional
Address: 4130 Linden Ave. Suite 390 Dayton, OH45432
Telephone Number: 937-258-1638
Substance Abuse Professional #2
Name:Kathleen Bowers
Title: Substance Abuse Professional
Address: 275 Medical Dr. Suite 1 . Anderson, IN 46082
Telephone Number:
HHS Certified Laboratory Primary Specimen
Name: Baptist Medical Center
Address: 11401-1-30, Little Rock, AR 72209-7056
Telephone Number: 501-202-7590
Drug and Alcohol Testing Policy (Zero Tolerance - v.0421) Page 27
PAGE 70F7213,.._